UMIN-CTR Clinical Trial

Recruitment status Enrolling by invitation
Unique ID issued by UMIN UMIN000015301
Receipt No. R000017254
Official scientific title of the study Information therapy using inaudible sounds for behavior and psychological symptoms (BPSD) of dementia
Date of disclosure of the study information 2014/10/01
Last modified on 2016/04/18 (Ver. 4)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Information therapy using inaudible sounds for behavior and psychological symptoms (BPSD) of dementia
Title of the study (Brief title) Information therapy for dementia
Region
Japan

Condition
Condition Patients of dementia with behavior and psychological symptoms (BPSD)
Classification by specialty
Psychiatry
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To evaluate safety and efficacy of information therapy using inaudible sounds for BPSD of dementia
Basic objectives2 Safety,Efficacy
Basic objectives -Others
Trial characteristics_1 Exploratory
Trial characteristics_2 Pragmatic
Developmental phase Phase I,II

Assessment
Primary outcomes Change from the baseline by the Neuropsychaitric Inventory(NPI) scores after 4-week information therapy
Key secondary outcomes Change from the baseline by the following items
1. EEG
2. MRI
3. Medication
4. Activities of daily living (ADL)
5. Mini Mental State Examination (MMSE)

Following items in relation to safety
5. Attrition rate of any cause
6. All adverse events

In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field.

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Treatment
Type of intervention
Other
Interventions/Control_1 Exposure of inaudible sounds for 4 weeks
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required.

Eligibility
Age-lower limit
65 years-old <=
Age-upper limit
90 years-old >
Gender Male and Female
Key inclusion criteria 1. Patients who meet criteria of major neurocognitive disorders by DSM-5
2. Patients who have one caregiver, who must live with the patient at least ten hours a week and must report the patient's behavior.
Key exclusion criteria 1. In case they show suicide attempt, excitement and violence.
2. In case they have history of developmental disorder, bipolar disorder or alchol/drug abuse.
3. In case they have hearing difficulties.
Target sample size 15

Research contact person
Name of lead principal investigator Manabu Honda
Organization National Center of Neurology and Psychiatry
Division name Department of Functional Brain Research, National Institute of Neuroscience
Address 4-1-1 Ogawa-Higashi, Kodaira, Tokyo 187-8551, Japan
TEL 042-346-1718
Email honda@ncnp.go.jp

Public contact
Name of contact person Yuichi Yamashita
Organization National Center of Neurology and Psychiatry
Division name Department of Functional Brain Research, National Institute
Address 4-1-1 Ogawa-Higashi, Kodaira, Tokyo 187-8551, Japan
TEL 042-346-1718
Homepage URL
Email yamay@ncnp.go.jp

Sponsor
Institute National Center of Neurology and Psychiatry
Institute
Department

Sponsor means an organization that is responsible for plan, deployment and
report of the research including funding management. It doesn't mean
funding agency". Therefore, all clinical trial should have the one.

Funding Source
Organization National Center of Neurology and Psychiatry
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor Foundation for advancement of international science
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2014 Year 10 Month 01 Day

Progress
Recruitment status Enrolling by invitation
Date of protocol fixation
2014 Year 05 Month 16 Day
Anticipated trial start date
2014 Year 10 Month 01 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2014 Year 10 Month 01 Day
Last modified on
2016 Year 04 Month 18 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000017254